Disulfiram neuropathy

Bahram Mokri; Akio Ohnishi; Peter James Dyck

doi:10.1212/wnl.31.6.730

Disulfiram neuropathy

Bahram Mokri, Akio Ohnishi, Peter James Dyck

Neurology

Research output: Contribution to journal › Article › peer-review

40 Scopus citations

Abstract

In four patients, sensorimotor polyneuropathy developed during treatment with disulfiram. Each patient began to improve with the cessation of treatment. Clinical, electrophysiologic, and pathologic observations point to a potentially reversible and probably dose-related axonal polyneuropathy.

Original language	English (US)
Pages (from-to)	730-735
Number of pages	6
Journal	Neurology
Volume	31
Issue number	6
DOIs	https://doi.org/10.1212/wnl.31.6.730
State	Published - Jun 1981

ASJC Scopus subject areas

Clinical Neurology

Access to Document

10.1212/wnl.31.6.730

Cite this

@article{8a7da7d5e2ff4462817f779da669e62f,

title = "Disulfiram neuropathy",

abstract = "In four patients, sensorimotor polyneuropathy developed during treatment with disulfiram. Each patient began to improve with the cessation of treatment. Clinical, electrophysiologic, and pathologic observations point to a potentially reversible and probably dose-related axonal polyneuropathy.",

author = "Bahram Mokri and Akio Ohnishi and Dyck, {Peter James}",

year = "1981",

month = jun,

doi = "10.1212/wnl.31.6.730",

language = "English (US)",

volume = "31",

pages = "730--735",

journal = "Neurology",

issn = "0028-3878",

publisher = "Lippincott Williams and Wilkins",

number = "6",

}

TY - JOUR

T1 - Disulfiram neuropathy

AU - Mokri, Bahram

AU - Ohnishi, Akio

AU - Dyck, Peter James

PY - 1981/6

Y1 - 1981/6

N2 - In four patients, sensorimotor polyneuropathy developed during treatment with disulfiram. Each patient began to improve with the cessation of treatment. Clinical, electrophysiologic, and pathologic observations point to a potentially reversible and probably dose-related axonal polyneuropathy.

AB - In four patients, sensorimotor polyneuropathy developed during treatment with disulfiram. Each patient began to improve with the cessation of treatment. Clinical, electrophysiologic, and pathologic observations point to a potentially reversible and probably dose-related axonal polyneuropathy.

UR - http://www.scopus.com/inward/record.url?scp=0019442026&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019442026&partnerID=8YFLogxK

U2 - 10.1212/wnl.31.6.730

DO - 10.1212/wnl.31.6.730

M3 - Article

C2 - 6264349

AN - SCOPUS:0019442026

SN - 0028-3878

VL - 31

SP - 730

EP - 735

JO - Neurology

JF - Neurology

IS - 6

ER -

Disulfiram neuropathy

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this